Rare disease market booming as more drugs reach market, gene therapy poses new drug pricing challenge

January 4, 2013

The Western world’s first drug to fix faulty genes promises to transform the lives of patients with an ultra-rare disease that clogs their blood with fat. The only snag is the price. (The Economic Times)